Evidence map›Paper›PMID 34110542›Full record

ArticleJournal of clinical immunology2021

Pulmonary Hypertension in Patients with Common Variable Immunodeficiency.

Pierre Thoré, Xavier Jaïs, Laurent Savale, Peter Dorfmuller, Athénaïs Boucly, Matthieu Devilder, Olivier Meyrignac, Jérémie Pichon, Julie Mankikian, Marianne Riou and 10 more

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of clinical immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.4field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Consideration of pulmonary hypertension in the evaluation of common variable immunodeficiency.Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 7 institutions in 2 countries.

Pierre ThoréAssistance Publique - Hôpitaux de Paris (AP-HP), Department of Respiratory and Intensive Care Medicine, Pulmonary Hypertension National Referral Center, Hôpital Bicêtre, Le Kremlin-Bicêtre, France.ORCID http://orcid.org/0000-0001-7378-2419
Xavier JaïsAssistance Publique - Hôpitaux de Paris (AP-HP), Department of Respiratory and Intensive Care Medicine, Pulmonary Hypertension National Referral Center, Hôpital Bicêtre, Le Kremlin-Bicêtre, France.ORCID http://orcid.org/0000-0002-4104-7994
Laurent SavaleAssistance Publique - Hôpitaux de Paris (AP-HP), Department of Respiratory and Intensive Care Medicine, Pulmonary Hypertension National Referral Center, Hôpital Bicêtre, Le Kremlin-Bicêtre, France.ORCID http://orcid.org/0000-0002-6862-8975
Peter DorfmullerDepartment of Pathology, University Hospital of Giessen and Marburg (UKGM), Giessen, Germany.ORCID http://orcid.org/0000-0003-2499-6829
Athénaïs BouclyAssistance Publique - Hôpitaux de Paris (AP-HP), Department of Respiratory and Intensive Care Medicine, Pulmonary Hypertension National Referral Center, Hôpital Bicêtre, Le Kremlin-Bicêtre, France.
Matthieu DevilderSchool of Medicine, University Paris-Saclay, Le Kremlin-Bicêtre, France.ORCID http://orcid.org/0000-0002-7685-5596
Olivier MeyrignacSchool of Medicine, University Paris-Saclay, Le Kremlin-Bicêtre, France.ORCID http://orcid.org/0000-0002-9744-9095
Jérémie PichonAssistance Publique - Hôpitaux de Paris (AP-HP), Department of Respiratory and Intensive Care Medicine, Pulmonary Hypertension National Referral Center, Hôpital Bicêtre, Le Kremlin-Bicêtre, France.
Julie MankikianCentre Hospitalier Régional Universitaire (CHRU) de Tours, Department of Pneumology, Hôpital Bretonneau, Tours, France.
Marianne RiouDepartment of Pneumology, Centre Hospitalier Universitaire (CHU) de Strasbourg, Nouvel Hôpital Civil (NHC) de Strasbourg, Strasbourg, France.ORCID http://orcid.org/0000-0001-6807-8582
Emmanuel BoiffardCentre Hospitalier Départemental (CHD) de Vendée, Department of Cardiology, Hôpital de La Roche sur Yon, La Roche sur Yon, France.
Clément BoissinCentre Hospitalier Universitaire (CHU) de Montpellier, Department of Pneumology, Hôpital Arnaud de Villeneuve, Montpellier, France.
Pascal De GrooteCentre Hospitalier Universitaire (CHU) de Lille, Department of Cardiology, Hôpital Albert Calmette, Lille, France.ORCID http://orcid.org/0000-0002-6211-0147
Céline ChabanneDepartment of Cardiology and Vascular Diseases, Cardio-pneumologic Center, Centre Hospitalier Universitaire (CHU) de Rennes, Rennes, France.ORCID http://orcid.org/0000-0001-9743-8743
Frédéric GagnadouxDepartment of Pneumology, Centre Hospitalier Universitaire (CHU) D'Angers, Angers, France.ORCID http://orcid.org/0000-0002-4231-5102
Anne BergeronUniversité de Paris, Assistance Publique - Hôpitaux de Paris (AP-HP), Department of Pneumology, Hôpital Saint-Louis, Paris, France.ORCID http://orcid.org/0000-0003-2156-254X
Nicolas NoelSchool of Medicine, University Paris-Saclay, Le Kremlin-Bicêtre, France.ORCID http://orcid.org/0000-0003-4055-617X
Olivier SitbonAssistance Publique - Hôpitaux de Paris (AP-HP), Department of Respiratory and Intensive Care Medicine, Pulmonary Hypertension National Referral Center, Hôpital Bicêtre, Le Kremlin-Bicêtre, France.ORCID http://orcid.org/0000-0002-1942-1951
Marc HumbertAssistance Publique - Hôpitaux de Paris (AP-HP), Department of Respiratory and Intensive Care Medicine, Pulmonary Hypertension National Referral Center, Hôpital Bicêtre, Le Kremlin-Bicêtre, France.ORCID http://orcid.org/0000-0003-0703-2892
David MontaniAssistance Publique - Hôpitaux de Paris (AP-HP), Department of Respiratory and Intensive Care Medicine, Pulmonary Hypertension National Referral Center, Hôpital Bicêtre, Le Kremlin-Bicêtre, France. david.montani@aphp.fr.ORCID http://orcid.org/0000-0002-9358-6922
Inserm · FRUniversité Paris-Saclay · FRCentre Hospitalier Départemental Vendée · FRCentre Hospitalier Universitaire de Tours · FRHôpital Civil, Strasbourg · FRLaboratoire Traitement du Signal et de l'Image · FRUniversitätsklinikum Gießen und Marburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeCommon variable immunodeficiency (CVID) is known to cause infectious, inflammatory, and autoimmune manifestations. Pulmonary hypertension (PH) is an unusual complication of CVID with largely unknown characteristics and mechanisms.

methodsWe report the clinical, functional, hemodynamics, radiologic and histologic characteristics, and outcomes of CVID-associated PH patients from the French PH Network.

resultsTen patients were identified. The median (range) age at CVID diagnosis was 36.5 (4-49) years and the median delay between CVID and PH diagnosis was 12 (0-30) years. CVID-associated PH affected predominantly women (female-to-male ratio 9:1). Most patients were New York Heart Association functional class III with a severe hemodynamic profile and frequent portal hypertension (n = 6). Pulmonary function tests were almost normal in 70% of patients and showed a mild restrictive syndrome in 30% of patients while the diffusing capacity for carbon monoxide was decreased in all but one patient. High-resolution computed tomography found enlarged mediastinal nodes, mild interstitial infiltration with reticulations and nodules. Two patients had a CIVD-interstitial lung disease, and one presented with bronchiectasis. Pathologic assessment of lymph nodes performed in 5 patients revealed the presence of granulomas (n = 5) and follicular lymphoid hyperplasia (n = 3). At last follow-up (median 24.5 months), 9 patients were alive, and one patient died of Hodgkin disease.

conclusionPH is a possible complication of CVID whose pathophysiological mechanisms, while still unclear, would be due to the inflammatory nature of CVID. CVID-associated PH presents as precapillary PH with multiple possible causes, acting in concert in some patients: a portal hypertension, a pulmonary vascular remodeling, sometimes a pulmonary parenchymal involvement and occasionally an extrinsic compression by mediastinal lymphadenopathies, which would be consistent with its classification in group 5 of the current PH classification.

Indexed as

AdolescentAdultAgedChildChild, PreschoolCommon Variable ImmunodeficiencyFemaleFranceHumansHypertension, PulmonaryLymph NodesMaleMiddle AgedPositron-Emission TomographyThoraxTomography, X-Ray ComputedCommon variable immunodeficiencyGranulomatous lymphocytic granulomasInterstitial lung diseasePulmonary hypertension

Identifiers

PMID34110542
OpenAlexW3166546914

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.